Skip to main content
Aviado Research · Pillar

Cardiovascular & Circulation

What the literature actually shows about supporting heart, vessels, and lipid handling — sorted by evidence tier, not by what’s loudest in marketing. Useful whether you track lipids on a dashboard or just want to age well.

44 supplements·84 articles·3 biomarkers·Last reviewed
All supplements in this pillar

Ranked by evidence tier.

Every supplement with published evidence for Cardiovascular & Circulation. Tiering reflects the strength of the primary literature, not market popularity.

Strong
Moderate
Preliminary
Insufficient
No supplements in this tier yet.
Complete index

Every article in Cardiovascular & Circulation

All 84 published Aviado Research articles in this pillar, linked in one place.

Frequently asked

Questions Aviado Research hears on this pillar.

Why does Aviado lead with Apo-B instead of LDL-C?

Editorial draft pending — Apo-B counts atherogenic particles directly; LDL-C estimates cholesterol per particle and can underestimate risk in metabolic dysfunction. Brief, citation-light, no testing-imperative.

How do evidence tiers apply to this pillar specifically?

Editorial draft pending — Restate the 4-tier rubric with cardiovascular examples. Note that hard outcome trials (MACE, mortality) are weighted more heavily than surrogate-endpoint trials when the literature offers both.

Where do supplements fit alongside statins, PCSK9s, or BP meds?

Editorial draft pending — Adjunct framing only. Aviado does not position supplements as substitutes for prescribed therapy. Cross-link to /methodology/ for how interaction risks are flagged.

How often is this pillar refreshed?

Editorial draft pending — Quarterly cadence; out-of-band re-reviews triggered by new meta-analyses, regulatory action (e.g. red-yeast-rice rulings), or safety signals.